BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1906157)

  • 1. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
    Hoffman-Liebermann B; Liebermann DA
    Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc.
    Hoffman-Liebermann B; Liebermann DA
    Mol Cell Biol; 1991 May; 11(5):2375-81. PubMed ID: 1901940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
    Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
    Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proto-oncogene expression and dissection of the myeloid growth to differentiation developmental cascade.
    Liebermann DA; Hoffman-Liebermann B
    Oncogene; 1989 May; 4(5):583-92. PubMed ID: 2471131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition.
    Abdollahi A; Lord KA; Hoffman-Liebermann B; Liebermann DA
    Cell Growth Differ; 1991 Aug; 2(8):401-7. PubMed ID: 1793735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor.
    Tanigawa T; Nicola N; McArthur GA; Strasser A; Begley CG
    Blood; 1995 Jan; 85(2):379-90. PubMed ID: 7811994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells.
    Selvakumaran M; Lin HK; Sjin RT; Reed JC; Liebermann DA; Hoffman B
    Mol Cell Biol; 1994 Apr; 14(4):2352-60. PubMed ID: 8139540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.
    Minami M; Inoue M; Wei S; Takeda K; Matsumoto M; Kishimoto T; Akira S
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3963-6. PubMed ID: 8632998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells.
    Suzuki R; Sakamoto H; Yasukawa H; Masuhara M; Wakioka T; Sasaki A; Yuge K; Komiya S; Inoue A; Yoshimura A
    Oncogene; 1998 Oct; 17(17):2271-8. PubMed ID: 9811457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma.
    Hatzi E; Murphy C; Zoephel A; Ahorn H; Tontsch U; Bamberger AM; Yamauchi-Takihara K; Schweigerer L; Fotsis T
    Eur J Biochem; 2002 Aug; 269(15):3732-41. PubMed ID: 12153570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloblastic leukemia cells conditionally blocked by myc-estrogen receptor chimeric transgenes for terminal differentiation coupled to growth arrest and apoptosis.
    Selvakumaran M; Liebermann D; Hoffman-Liebermann B
    Blood; 1993 May; 81(9):2257-62. PubMed ID: 8481508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting effect of IFN-gamma and IFN-alpha/beta on differentiation of some clones of mouse myeloid leukemic cells.
    Yamamoto-Yamaguchi Y; Tomida M; Hozumi M
    Leuk Res; 1989; 13(3):253-7. PubMed ID: 2496278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
    Yen A; Samuel V; Forbes M
    J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.
    Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
    FEBS Lett; 1991 Oct; 291(2):181-4. PubMed ID: 1936261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.
    Cambier N; Zhang Y; Vairo G; Kosmopoulos K; Metcalf D; Nicola NA; Elefanty AG
    Oncogene; 1999 Jan; 18(2):343-52. PubMed ID: 9927191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.